Pain & Mood
By M3 Information · November 19, 2026
About a 2-minute readNew NIH reporting on pain research points to treating the whole person, mood and sleep included.
The September 2026 issue of NIH News in Health looks at where pain treatment is heading. Opioids relieve pain but carry risks of overdose and addiction, and doctors now prescribe them less often. That is a sound trend, though it leaves some people with pain that is not well controlled.
Two lines of research aim to close that gap. A team led by Dr. Steven Olson at Sanford Burnham Prebys is designing molecules that act on a different receptor, neurotensin receptor 1, to bring relief with fewer side effects. At Brigham and Women’s Hospital and Harvard Medical School, Dr. William Renthal’s group mapped the nerve cells along the spine and is using that map to build gene therapies that quiet pain-sensing cells while leaving touch and other sensations alone.
New drugs take years. In the meantime, NIH lists options that carry little risk and can be discussed with a doctor:
At NIH’s own chronic pain clinic, each patient is seen by a full team that includes neurologists, psychologists, nutritionists and physical therapists. Dr. Miroslav Bačkonja of NIH describes the clinic’s method as taking “a whole-person perspective.”
Pain that goes on for months often travels with low mood, anxiety and poor sleep, and each can make the others harder to treat. That is why the M3 review pairs its mental health checklist with a pain scale. You get one report that shows both, ready to take to your doctor.
One brief, private report covering pain and mental health. It is informational and is not a diagnosis.
Take the M3 reviewSource: NIH News in Health, September 2026, “Chronic Pain Treatment: The Search for New Options.”
NIH material is not copyrighted. This post is M3’s summary; NIH has not reviewed or endorsed it. This post is general information, not medical advice. Talk with your doctor about treatment. If you are in crisis, call or text 988.
← Back to all articles